RxDoctor Payments Data

William Granberry, MD

Foot and Ankle Surgery · Houston, TXNPI 1134162605

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $74,490 of the $83,899 with a category attached, or 88.8%. Arthrex accounts for 92.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $33,334 and has fallen 91.2% since, to $2,930 in 2025. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,899in general payments, 2019–2025

Across 118 payments — averaging $711.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$78K
  • Medinc Of Texas$3K
  • Stryker$2K
  • Paragon 28, Inc.$796
  • Johnson & Johnson$112
  • Bioventus LLC$70
  • plus $243 from 5 others
$70,750in research payments, 2019–2025

Across 27 payments — averaging $2620.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ferring International Pharmascience Center US$54K
  • Stryker$17K

What the payments were for

  • Royalty or licence$74,49089%
  • Travel & lodging$3,7324%
  • Food & beverage$3,2774%
  • Education$2,4003%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex58$77,677
Medinc Of Texas11$3,019
Stryker(2 entities)26$1,980
Paragon 28, Inc.8$796
Johnson & Johnson3$112
Bioventus LLC3$70
Treace Medical Concepts, Inc.3$70
Ossur Americas, Inc.3$49
Smith+Nephew1$47
Globus Medical1$40
Acumed LLC1$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,899 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$65,213
Medicare patients
204
Services billed
1,767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$558
Meloxicam111$483
Celecoxib39$463
Tramadol Hcl37$140

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →